New stock news | Jinying Jia's Hong Kong IPO prospectus is invalid
Jiyinga Technology (Shaoxing) Co., Ltd. (referred to as Jiyinga) submitted its Hong Kong IPO prospectus on December 21, 2025, which expired after 6 months on June 21, 2026. At the time of submission, CCB International and Minsheng Capital were its joint sponsors.
The Hong Kong IPO prospectus submitted by Jiyinjia Technology (Shaoxing) Co., Ltd. (referred to as Jiyinjia) on December 21, 2025, will expire after 6 months on June 21, 2026. At the time of submission, Jianyin International and CMBC CAPITAL were its joint sponsors.
The prospectus shows that Jiyinjia is a leading precision medical company in China, deeply integrating AI capabilities into various core aspects of the bio-marker value chain. The company is committed to accelerating the AI-driven multi-omics technology towards large-scale clinical applications through an innovative framework that combines multi-omics and AI synergistically, in order to better serve the increasing unmet critical medical needs of the vast patient population in China.
Related Articles
FUTONG TECH (00465) issued 18,000 shares due to the exercise of stock options.
Zhou Heiya (01458) spent approximately HK$646,600 to repurchase 512,500 shares on June 22nd.
On June 22, FLAT GLASS (06865) spent 9.9988 million Hong Kong dollars to buy back 1.47 million shares.
FUTONG TECH (00465) issued 18,000 shares due to the exercise of stock options.
Zhou Heiya (01458) spent approximately HK$646,600 to repurchase 512,500 shares on June 22nd.
On June 22, FLAT GLASS (06865) spent 9.9988 million Hong Kong dollars to buy back 1.47 million shares.
RECOMMEND
